Skip to content
Close
SEARCH
Join Mailing List
Join Mailing List
IPC_HH_2025_L6A3551

CONFERENCE SPEAKERS & PROGRAM

THEMES & CONFIRMED SPEAKERS

Theme 1: Gaps in Glomerular Disease Clinical Trials: Where Are We Today?

Brad Rovin, The Ohio State University
Jonathan Barratt, University of Leicester
Laurel Damashek, International Society of Glomerular Disease
Liz Lightstone, ISN President-Elect, Imperial College London
Marina Vivarelli, Bambino Gesù Children's Hospital, IRCCS
Theme 2: Emerging Biomarkers and Treatment Targets in GD Clinical Trials

Alexander Duncan, Walden Biosciences 
Alice Brown, PureSpring Therapeutics
Jonathan Hogan, Cabaletta Bio
Laura Mariani, University of Michigan
Nicola Tomas, UKE Hamburg
Vineet Gupta, UTMB
Theme 3: Past Lessons and Future Vision Ana Malvar, University of Buenos Aires
Daniel Gale, University College London
Hiddo Heerspink, University Medical Center Groningen
Katherine Tuttle, Providence Health Care, University of Washington
Kirk Campbell, NKF President, University of Pennsylvania
Matthias Kretzler, University of Michigan
Meg Jardine, University of Sydney
Muh Geot Wong, University of Sydney
Patrick Nachman, University of Minnesota
Sean Barbour, University of British Columbia
Suceena Alexander, Christian Medical College, Vellore
Vlado Perkovic, UNSW Sydney
Theme 4: Regulatory Advances Abigail Smith, Northwestern University
Alex Mercer, JAMCO Pharma Consulting
Barbara Gillespie, International Society of Glomerular Disease, University of North Carolina
Brendon Neuen, The George Institute for Global Health
Eloise Salmon, University of Michigan
Hiddo Heerspink, University Medical Center Groningen
Lesley Inker, Tufts University School of Medicine
Louise Oni, University of Liverpool, UCL and Great Ormond Street Hospital for Children
Priya Verghese, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University
Tom Greene, University of Utah Health 
Vlado Perkovic, UNSW Sydney
Theme 5: Breaking Barriers for Successful Trial Recruitment and Execution Barbara Gillespie, International Society of Glomerular Disease, University of North Carolina
Josh Tarnoff, NephCure
Jula Inrig, Travere Therapeutics
Jule Pinter, UKE Hamburg
Shikha Wadhwani, UTMB
Susan Brisendine, NephCure
Sydney Tang, University of Hong Kong
Tobias B. Huber, International Society of Glomerular Disease, UKE Hamburg
Uptal Patel, Biogen

AGENDA HIGHLIGHTS

Subject to change; full agenda forthcoming
  • Day 1: Friday Nov 13
  • Day 2: Saturday Nov 14
  • Day 3: Sunday November 15

10:30 am

PROGRAM BEGINS

Gaps in Glomerular Disease Clinical Trials: Where Are We Today?

Highlights from 2025-26 Conferences

Voice of the Patient

Emerging Biomarkers & Treatment Targets in GD Clinical Trials

  • Gene Delivery to the Podocyte
  • Cellular Therapy and Bispecific Antibodies for GD

Voice of Pharma: Translating Science into Therapeutics (Panel)

Past Lessons and Future Vision for GD Trials

  • Lessons Learned in Past GD trials
  • Evolving Trial Design & Endpoints

5:45 PM

PROGRAM ENDS

8:00 am

PROGRAM BEGINS

Voice of the FDA: What Keeps Us Up at Night (Panel)

Unmet Needs in Other Patient Populations

  • Pediatric Extrapolation
  • Trials in Transplant Patients

Should the Trial Proceed? DSMB Dilemmas

Voice of Healthcare Institutions' Leaders (Panel)

Poster Sessions

4:15 pm

PROGRAM ENDS

9:00 am

PROGRAM BEGINS

Breaking Barriers for Successful TrialRecruitment & Execution

  • GD Centers of Excellence
  • Recruiting More than 1 Patient at Each Site
  • Trial Operations Solutions

Voice of Pharma's C-Suite: What Keeps Us Up at Night (Panel)

Late Breaking Research

Voice of the Clinical Trials Village (Panel)

1:00 pm

PROGRAM ENDS